Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 48.81 is 138% above its 5-year average of 20.52, near the high end of its 5-year range (1.80–48.81).
As of the fiscal period ended Tuesday, June 30, 2026. 46.52% above its 12-month average of 33.31.
Reported quarterly current ratio; no daily interpolation. Q4 FY2026 (2026-06-30): 48.81.
CURRENT RATIO
48.81
CURRENT RATIO AVG TTM
33.31
CURRENT RATIO AVG 3Y
17.19
CURRENT RATIO AVG 5Y
20.52
CURRENT RATIO AVG 10Y
9.82
CURRENT RATIO AVG 15Y
3.61
CURRENT RATIO AVG 20Y
3.21
CURRENT VS TTM AVG
+46.52%
CURRENT VS 3Y AVG
+183.93%
CURRENT VS 5Y AVG
+137.88%
CURRENT VS 10Y AVG
+396.94%
CURRENT VS 15Y AVG
+1253.30%
CURRENT VS 20Y AVG
+1418.94%
SECTOR MEDIAN · HEALTHCARE
3.67
median of 830 covered companies
CURRENT VS SECTOR MEDIAN
+1228.21%
vs the sector median at left
Incannex Healthcare Limited
Market Cap
$37.75M
Current Ratio
48.81
TTM Avg
33.31
3Y Avg
17.19
5Y Avg
20.52
Market Cap
$37.45M
Current Ratio
3.10
TTM Avg
1.66
3Y Avg
0.84
5Y Avg
1.97
Market Cap
$38.92M
Current Ratio
1.87
TTM Avg
1.51
3Y Avg
1.77
5Y Avg
1.99
Market Cap
$36.69M
Current Ratio
2.77
TTM Avg
2.09
3Y Avg
1.85
5Y Avg
2.65
Market Cap
$39.53M
Current Ratio
4.50
TTM Avg
7.06
3Y Avg
6.43
5Y Avg
6.01
Market Cap
$40.42M
Current Ratio
2.08
TTM Avg
2.23
3Y Avg
2.23
5Y Avg
2.23
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Incannex Healthcare Limited (IXHL) | $37.75M | 48.81 | 33.31 | 17.19 | 20.52 |
| QT Imaging Holdings, Inc. (QTI)vs › | $37.45M | 3.10 | 1.66 | 0.84 | 1.97 |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.92M | 1.87 | 1.51 | 1.77 | 1.99 |
| Edesa Biotech, Inc. (EDSA)vs › | $37.09M | 2.76 | 5.79 | 4.84 | 5.49 |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.69M | 2.77 | 2.09 | 1.85 | 2.65 |
| Metagenomi, Inc. Common Stock (MGX)vs › | $39.53M | 4.50 | 7.06 | 6.43 | 6.01 |
| Nephros, Inc. (NEPH)vs › | $36.26M | 4.07 | 4.68 | 4.80 | 6.06 |
| DocGo Inc. (DCGO)vs › | $35.76M | 1.66 | 2.38 | 2.37 | 2.73 |
| Filana Therapeutics, Inc. (FLNA)vs › | $40.42M | 2.08 | 2.23 | 2.23 | 2.23 |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.23M | 7.07 | 2.75 | 16.37 | 28.22 |
Current Ratio
48.81
Quick Ratio
48.81
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 48.81 |
| 2025-12-31 | 48.27 |
| 2025-06-30 | 2.86 |
| 2024-12-31 | 1.80 |
| 2024-06-30 | 2.88 |
| 2023-12-31 | 6.70 |
| 2023-06-30 | 9.02 |
| 2022-12-31 | 37.63 |
| 2022-06-30 | 18.84 |
| 2021-12-31 | 36.54 |
| 2021-06-30 | 12.36 |
| 2020-12-31 | 32.19 |
| 2020-06-30 | 3.95 |
| 2019-12-31 | 14.07 |
| 2019-06-30 | 0.41 |
| 2018-12-31 | 1.30 |
| 2018-06-30 | 0.49 |
| 2017-12-31 | 1.83 |
| 2017-06-30 | 1.09 |
| 2016-12-31 | 2.56 |
| 2016-06-30 | 0.11 |
| 2015-12-31 | 1.95 |
| 2015-06-30 | 1.08 |
| 2014-12-31 | 0.49 |
| 2014-06-30 | 1.79 |
| 2013-12-31 | 5.21 |
| 2013-06-30 | 1.01 |
| 2012-12-31 | 0.63 |
| 2012-06-30 | 0.40 |
| 2011-12-31 | 0.47 |
| 2011-06-30 | 0.48 |
| 2010-12-31 | 3.43 |
| 2010-06-30 | 1.37 |
| 2009-12-31 | 1.86 |
| 2009-06-30 | 0.87 |
| 2008-12-31 | 0.23 |
| 2008-06-30 | 1.30 |
| 2007-12-31 | 26.27 |
| 2007-06-30 | 41.62 |
